Preclinical Demonstration of a Novel Treatment with High Efficacy and No Detectable Toxicity for Inflammatory Skin Conditions including Psoriasis

Table 2

Allopurinol altered gene expression is PSE cells, 2 days post treatment.

Trt	Ki67	p21	IL17A	IL23A	TNFα	TGFβ
Control
0.5 mM allopurinol
3 mM allopurinol
3 mM glutathione
3 mM A+3 mM GSH
100 nM VitD